“A+H”股热潮延续，9月累计20家A股上市公司筹划赴港上市

Core Viewpoint - The trend of A-share companies planning to list in Hong Kong continues, with 20 companies announcing their intentions in September 2023, indicating a strong interest in expanding their market presence and capitalizing on international opportunities [1][5][6]. Group 1: Companies Planning to List - 20 A-share companies have announced plans to issue H-shares and list on the Hong Kong Stock Exchange, including notable names such as 博瑞医药, 五芳斋, 海澜之家, and 海亮股份 [1]. - 博瑞医药 plans to issue H-shares and has completed clinical research for its weight loss drug BGM0504, with IND applications approved in the U.S. [5]. - 五芳斋 aims to issue H-shares and is preparing for the mid-autumn sales season with a strategy focused on high-end product customization and online marketing [5]. - 海澜之家 intends to issue H-shares and is enhancing its product lines with a focus on technology and environmental quality [6]. - 海亮股份 is also planning to issue H-shares, with significant collaborations in the copper processing sector and expectations for its copper foil business to reach breakeven by 2026 [7]. - 科大智能 is preparing to issue H-shares and has previously supplied robotic products to Tesla, although the revenue contribution is minor [7]. Group 2: Market Performance and Strategic Developments - 东山精密, a leading PCB manufacturer, is planning to issue H-shares to enhance its international strategy and has seen its stock price reach a historical high of 86.33 yuan per share, with a maximum increase of 300% since April [1]. - 沪电股份, another major PCB manufacturer, is also planning to issue H-shares, with its stock price hitting a historical high of 84.45 yuan per share and a maximum increase of 264% since April [3].